Edgewise Therapeutics (EWTX) News Today $12.96 -0.06 (-0.42%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$12.96 0.00 (0.00%) As of 07/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EWTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy TreatmentJuly 4 at 6:30 AM | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX - MorningstarJuly 3 at 8:04 PM | morningstar.comMEdgewise Therapeutics, Inc. (EWTX) Cash Flow - Yahoo FinanceJuly 3 at 8:04 PM | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 3 at 10:00 AM | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Edgewise Therapeutics (EWTX) and Arcturus Therapeutics (ARCT)July 2 at 10:52 PM | theglobeandmail.com13 Best Up and Coming Stocks to Invest In NowJuly 2 at 12:49 PM | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 2 at 10:00 AM | prnewswire.comWhat is HC Wainwright's Forecast for EWTX Q2 Earnings?July 2 at 7:41 AM | marketbeat.comEdgewise Therapeutics stock initiated with Buy rating at H.C. WainwrightJuly 1 at 10:47 PM | investing.comHC Wainwright Initiates Coverage on Edgewise Therapeutics (NASDAQ:EWTX)July 1 at 2:59 AM | americanbankingnews.comHC Wainwright & Co. Initiates Coverage of Edgewise Therapeutics (EWTX) with Buy RecommendationJune 30, 2025 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up - Should You Buy?June 30, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Earns Buy Rating from Analysts at HC WainwrightJune 30, 2025 | marketbeat.comEdgewise Therapeutics stock holds at $16 target amid trial concernsJune 27, 2025 | investing.comEdgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies - Yahoo FinanceJune 27, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJune 27, 2025 | prnewswire.comEdgewise Therapeutics stock falls after FDA deems data insufficient for accelerated approvalJune 26, 2025 | za.investing.comEdgewise falls after data for muscular dystrophy therapyJune 26, 2025 | msn.comEdgewise Therapeutics Shares Drop After FDA Withholds Accelerated Approval for Muscle Disorder DrugJune 26, 2025 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - Here's WhyJune 26, 2025 | marketbeat.comEdgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular DystrophiesJune 26, 2025 | prnewswire.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Boosted by GAMMA Investing LLCJune 18, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 3.8% - What's Next?June 16, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and Edgewise Therapeutics (EWTX)June 13, 2025 | theglobeandmail.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 10, 2025 | marketbeat.comBank of America Corp DE Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)June 6, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Earns Outperform Rating from Royal Bank of CanadaJune 5, 2025 | marketbeat.com22,584 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Ameriprise Financial Inc.June 4, 2025 | marketbeat.comEdgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare ConferenceJune 3, 2025 | prnewswire.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $2.40 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)June 3, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)June 2, 2025 | marketbeat.comTwo Sigma Investments LP Sells 129,791 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 31, 2025 | marketbeat.comEdgewise Therapeutics: Upcoming DMD Trial Data May DisappointMay 29, 2025 | seekingalpha.comNuveen Asset Management LLC Acquires 158,452 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 29, 2025 | marketbeat.comPolar Asset Management Partners Inc. Sells 93,300 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 28, 2025 | marketbeat.comEdgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challengesMay 25, 2025 | uk.investing.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Woodline Partners LPMay 24, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 24, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Reduces Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Buys Shares of 106,562 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 23, 2025 | marketbeat.com183,300 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Soleus Capital Management L.P.May 21, 2025 | marketbeat.comTang Capital Management LLC Invests $8.01 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 20, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Deutsche Bank AGMay 20, 2025 | marketbeat.comEnsign Peak Advisors Inc Acquires New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 18, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $624,000 in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 18, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by AnalystsMay 18, 2025 | marketbeat.comNorthern Trust Corp Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 17, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) is MPM Bioimpact LLC's 3rd Largest PositionMay 16, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock Position Raised by Paradigm Biocapital Advisors LPMay 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Sells 275,897 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)May 16, 2025 | marketbeat.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼0.610.54▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼196▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Telix Pharmaceuticals News Today TG Therapeutics News Today Lantheus News Today Nuvalent News Today Axsome Therapeutics News Today Akero Therapeutics News Today Vaxcyte News Today ADMA Biologics News Today PTC Therapeutics News Today Rhythm Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
